Test your basic knowledge |

First Aid Basics

Subjects : health-sciences, first-aid

Instructions:

Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can study here.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.

1. Astrocytoma - angiomyolipoma - cardiac rhabdomyoma
Leukocyte extravasation: migration
smooth muscle benign tumor
causes of increased ESR
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)

2. Secondary osteosarcoma and fibrosarcoma

Warning: Invalid argument supplied for foreach() in /var/www/html/basicversity.com/show_quiz.php on line 183

3. Hyperplasia - metaplasia - dysplasia
causes of increased ESR
fat malignant tumor
Reversible - plasias
Pale infarcts

4. AL
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
fat benign tumor
calcitonin
primary amyloidosis

5. Tumor marker: prostate carcinoma marker.
Second - leading cause of death in the US
skeletal muscle malignant tumor
alpha - fetoprotein
Prostatic acid phosphatase

6. Skin (SqCC) - liver (angiosarcoma)
L- myc gene
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
arsenic target
PSA

7. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
fat benign tumor
bone malignant tumor
Primary tumors that met to brain
bone benign tumor

8. All - AML
Neoplasm associated with Down Syndrome
Rb gene
Bombesin
cigarette smoke target

9. Heart disease
Leukocyte extravasation: tight binding
blood vessels malignant tumor
Leading cause of death in the US
Acute inflammatory mediators

10. Osteoma
CA-19-9
Free radical eliminators
bone benign tumor
paraneoplastic effects of renal cell carcinoma - hemangioblastoma

11. Tumor marker: neuroblastoma - lung and gastric cancer
prostate cancer incidence/mortality
Free radical eliminators
Bombesin
CA-19-9

12. Tumor marker: pancreatic adenocarcinoma
ret gene
CA-19-9
secondary amyloidosis (reactive systemic)
Primary tumors that met to liver

13. Liver (angiosarcoma)
vinyl chloride target
Pale infarcts
benign epithelial tumor
Barrett's esophagus (chronic GI reflux)

14. Enzymatic degradation and protein denaturation due to exogenous injury. Inflammatory process where intracellular components extravasate.
Necrosis
Red (hemorrhagic) infarcts
iron poisoning
prostate cancer incidence/mortality

15. CML tyrosine kinase (oncogene)
abl gene
Pale infarcts
AIDS
granulomatous disease

16. 32%/13% male
prostate cancer incidence/mortality
paraneoplastic effects of leukemias and lymphomas
c - kit gene
intrinsic apoptosis

17. Wilms' tumor 11p tumor suppressor
Leukocyte extravasation: diapedesis
Neoplasm associated with Down Syndrome
WT1 gene
skeletal muscle malignant tumor

18. PTH- related peptide - TGF- beta - TNF - IL-1
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
p53 gene
CA-125
prostate cancer incidence/mortality

19. 32%/18% female
ret gene
beta - hCG
Leukocyte extravasation: rolling
breast cancer incidence/mortality

20. Gastric adenocacinoma
AIDS
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
Primary tumors that met to bone
blood vessels benign tumor

21. Follicular and undifferentiated lymphomas anti - apoptotic molecule (oncogene)
DPC gene
arsenic target
bcl -2 gene
CCl4 target

22. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.
Chronic inflammatory mediators
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
paraneoplastic effects of small cell lung carcinoma
beta - hCG

23. Liposarcoma
N- myc gene
Neoplasm associated with Down Syndrome
fat malignant tumor
skeletal muscle benign tumor

24. Breast cancer 13q tumor suppressor (DNA repair protein)
calcitonin
Primary tumors that met to brain
BRAC2 gene
Red (hemorrhagic) infarcts

25. Melanoma 9p tumor suppressor
bone malignant tumor
arsenic target
Primary tumors that met to liver
p16 gene

26. Adenoma - papilloma
ret gene
benign epithelial tumor
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
CA-125

27. Rhabdomyosarcoma
skeletal muscle malignant tumor
paraneoplastic effects of leukemias and lymphomas
DPC gene
Napthalene (aniline) dyes target

28. Breast - ovarian and gastric carcinomas tyrosine kinase (oncogene)
erb - B2 gene
L- myc gene
Free radical eliminators
primary amyloidosis

29. GIST cytokine receptor (oncogene)
c - kit gene
NF2 gene
BRCA1 gene
Bombesin

30. Breast and ovarian cancer 17q tumor suppressor (DNA repair protein)
NF1 gene
paraneoplastic effects of small cell lung carcinoma
BRCA1 gene
breast cancer incidence/mortality

31. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.
PSA
Second - leading cause of death in the US
malignant epithelial tumor
Primary tumors that met to bone

32. Enzymes: catalase - superoxide dismutase - glutathione peroxidase.Vitamins: ACE Spontaneous decay
Free radical eliminators
Alk - phos
bone malignant tumor
p53 gene

33. AA
DPC gene
iron poisoning
arsenic target
secondary amyloidosis (reactive systemic)

34. Lung - liver - intestine or following reperfusion.
acanthosis nigricans (hyperpig and epidermal thickening)
N- myc gene
Red (hemorrhagic) infarcts
benign epithelial tumor

35. Female 13%/23% and rising Male 16%/33% (mortality has plateaued)
S-100
lung cancer incidence/mortality
N- myc gene
Alk - phos

36. Neutrophils (eos in the gut) - plus other granular leukocytes and antibodies.
Leukocyte extravasation: tight binding
Rb gene
Acute inflammatory mediators
ulcerative colitis

37. Leiomyosarcoma
N- myc gene
Leukocyte extravasation: diapedesis
smooth muscle malignant tumor
p16 gene

38. TB - fungal infections - syphilis - leprosy - cat scratch fever - sarcoid - Crohn's - Berylliosis.
skeletal muscle benign tumor
granulomatous disease
paraneoplastic effects of leukemias and lymphomas
extrinsic apoptosis

39. Sickle cell (altered shape) - polycythemia (too many) - CHF (unknown)
causes of decreased ESR
skeletal muscle malignant tumor
Neoplasm associated with actinic keratosis
CA-125

40. Sarcoma - papillary thyroid cancer
causes of increased ESR
blood cell malignant tumors
radiation exposure
Where you see Psammoma bodies

41. Macrophages and lymphocytes. Persistant destruction and repair.
Alkylating agents target
Chronic inflammatory mediators
N- myc gene
malignant mesenchyme tumor (general)

42. Colorectal cancer (assoc with FAP) 5q tumor suppressor
APC gene
malignant mesenchyme tumor (general)
dysplastic nevus
cirrosis (alcohol - hepB or C)

43. Bladder (transitional cell carcinoma)
calcitonin
breast cancer incidence/mortality
Napthalene (aniline) dyes target
intrinsic apoptosis

44. Tumor marker: melanoma - neural tumors - astrocytomas
S-100
N- myc gene
Chronic inflammatory mediators
Leukocyte extravasation: migration

45. Lung tumor transcription factor (oncogene)
aflatoxin target
N- myc gene
malignant mesenchyme tumor (general)
L- myc gene

46. PECAM-1
breast cancer incidence/mortality
Leukocyte extravasation: diapedesis
paraneoplastic effects of small cell lung carcinoma
asbestos target

47. Tumor marker: ovarian - malignant epithelial tumors.
vinyl chloride target
Napthalene (aniline) dyes target
Pale infarcts
CA-125

48. Colon>stomach>pancreas>breast>lung (liver and lung are the most common places for mets)
Primary tumors that met to liver
iron poisoning
Free radical cell damage
aflatoxin target

49. Ligand - receptor interactions. Release of perforin and granzyme B.
extrinsic apoptosis
skeletal muscle malignant tumor
TRAP
smooth muscle malignant tumor

50. Erythropoietin
arsenic target
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
Chronic inflammatory mediators